Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Seidman

Showing results (411-420 of 533) with videos related to

Pageof 54
Sort By:
Science (New York, N.Y.)|February 26, 2016
A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in miceEric M Green, Hiroko Wakimoto, Robert L Anderson, et al.
Nature Communications|September 23, 2018
Hierarchical and stage-specific regulation of murine cardiomyocyte maturation by serum response factorYuxuan Guo, Blake D Jardin, Pingzhu Zhou, et al.
Circulation Research|September 10, 2019
Yin Yang 1 Suppresses Dilated Cardiomyopathy and Cardiac Fibrosis Through Regulation of <i>Bmp7</i> and <i>Ctgf</i>Chia Yee Tan, Jing Xuan Wong, Pui Shi Chan, et al.
Bioinformatics (Oxford, England)|March 24, 2019
ORE identifies extreme expression effects enriched for rare variantsF Richter, G E Hoffman, K B Manheimer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 4, 2015
CORRIGENDUM: Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivityAhmed A Alfares, Melissa A Kelly, Gregory McDermott, et al.
Circulation. Cardiovascular Genetics|August 12, 2017
Fabry Disease in Families With Hypertrophic Cardiomyopathy: Clinical Manifestations in the Classic and Later-Onset PhenotypesBerglind Adalsteinsdottir, Runolfur Palsson, Robert J Desnick, et al.
Circulation|March 29, 2018
Spatiotemporal Multi-Omics Mapping Generates a Molecular Atlas of the Aortic Valve and Reveals Networks Driving DiseaseFlorian Schlotter, Arda Halu, Shinji Goto, et al.
Science (New York, N.Y.)|August 29, 2015
HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathyJohn T Hinson, Anant Chopra, Navid Nafissi, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 23, 2015
Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivityAhmed A Alfares, Melissa A Kelly, Gregory McDermott, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 1999
Different TBX5 interactions in heart and limb defined by Holt-Oram syndrome mutationsC T Basson, T Huang, R C Lin, et al.
Pageof 54

Showing results (411-420 of 533) with videos related to

Sort By:
Pageof 54
Science (New York, N.Y.)|February 26, 2016
A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in miceEric M Green, Hiroko Wakimoto, Robert L Anderson, et al.
Nature Communications|September 23, 2018
Hierarchical and stage-specific regulation of murine cardiomyocyte maturation by serum response factorYuxuan Guo, Blake D Jardin, Pingzhu Zhou, et al.
Circulation Research|September 10, 2019
Yin Yang 1 Suppresses Dilated Cardiomyopathy and Cardiac Fibrosis Through Regulation of <i>Bmp7</i> and <i>Ctgf</i>Chia Yee Tan, Jing Xuan Wong, Pui Shi Chan, et al.
Bioinformatics (Oxford, England)|March 24, 2019
ORE identifies extreme expression effects enriched for rare variantsF Richter, G E Hoffman, K B Manheimer, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 4, 2015
CORRIGENDUM: Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivityAhmed A Alfares, Melissa A Kelly, Gregory McDermott, et al.
Circulation. Cardiovascular Genetics|August 12, 2017
Fabry Disease in Families With Hypertrophic Cardiomyopathy: Clinical Manifestations in the Classic and Later-Onset PhenotypesBerglind Adalsteinsdottir, Runolfur Palsson, Robert J Desnick, et al.
Circulation|March 29, 2018
Spatiotemporal Multi-Omics Mapping Generates a Molecular Atlas of the Aortic Valve and Reveals Networks Driving DiseaseFlorian Schlotter, Arda Halu, Shinji Goto, et al.
Science (New York, N.Y.)|August 29, 2015
HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathyJohn T Hinson, Anant Chopra, Navid Nafissi, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 23, 2015
Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivityAhmed A Alfares, Melissa A Kelly, Gregory McDermott, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 1999
Different TBX5 interactions in heart and limb defined by Holt-Oram syndrome mutationsC T Basson, T Huang, R C Lin, et al.
Pageof 54